000 01631 a2200469 4500
005 20250517040002.0
264 0 _c20160512
008 201605s 0 0 eng d
022 _a1791-3004
024 7 _a10.3892/mmr.2015.3967
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYin, Tao
245 0 0 _aDopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model.
_h[electronic resource]
260 _bMolecular medicine reports
_cSep 2015
300 _a4103-4108 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBreast Neoplasms
_xblood supply
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDopamine Antagonists
_xtoxicity
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKi-67 Antigen
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNeovascularization, Pathologic
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aSTAT3 Transcription Factor
_xmetabolism
650 0 4 _aThioridazine
_xtoxicity
650 0 4 _aTranscription Factor RelA
_xmetabolism
700 1 _aHe, Sisi
700 1 _aShen, Guobo
700 1 _aYe, Tinghong
700 1 _aGuo, Fuchun
700 1 _aWang, Yongsheng
773 0 _tMolecular medicine reports
_gvol. 12
_gno. 3
_gp. 4103-4108
856 4 0 _uhttps://doi.org/10.3892/mmr.2015.3967
_zAvailable from publisher's website
999 _c25002281
_d25002281